Literature DB >> 12176136

Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta.

Yoshinari Uehara1, Hidenori Urata, Munehito Ideishi, Kikuo Arakawa, Keijiro Saku.   

Abstract

OBJECTIVE: The role of chymase (a mast cell-derived angiotensin II-forming serine proteinase) in aortic lipid deposition was investigated using an orally active, non-peptide chymase inhibitor, SUN-C8257.
METHODS: Male golden Syrian hamsters, 8 weeks old, were fed with a standard rodent meal supplemented with or without 0.5% cholesterol and 10% coconut oil for 12 weeks. The hamsters fed high cholesterol diet were further separated into two groups treated with or without SUN-C8257 for 12 weeks. The aortic lipid deposition was visualized by Oil red O staining and planimetrically measured. Immunohistochemical staining for angiotensin II (Ang II) of the aortic root region was performed. Aortic Ang II-forming activity was measured using Ang I as a substrate. Plasma total-, low-density lipoprotein (LDL)-, high-density lipoprotein (HDL)-cholesterol and triglyceride were quantified by enzymatic methods. Plasma Ang I and Ang II were measured by radioimmunoassay.
RESULTS: After 12 weeks of high cholesterol diet, aortic chymase activity in the untreated group increased significantly and showed a positive correlation with plasma total- and LDL-cholesterol. This group of hamsters developed marked lipid deposits in the aortic intima. However, treatment with SUN-C8257 significantly suppressed aortic lipid deposition without changing body weight, blood pressure, plasma LDL-cholesterol and Ang II levels. The level of the adventitial Ang II-immunoreactivity was markedly inhibited in the group treated with SUN-C8257.
CONCLUSION: Our results suggest that arterial chymase may participate in the acceleration of lipid deposition in arterial walls exposed to high plasma cholesterol and that inhibition of arterial chymase may retard the progression of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176136     DOI: 10.1016/s0008-6363(02)00458-3

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  12 in total

Review 1.  Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases.

Authors:  Jia-Ming Xu; Guo-Ping Shi
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

Review 2.  Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.

Authors:  Yanwen Qin; Guo-Ping Shi
Journal:  Pharmacol Ther       Date:  2011-05-12       Impact factor: 12.310

3.  The renin angiotensin system and the metabolic syndrome.

Authors:  Chih-Hong Wang; Feng Li; Nobuyuki Takahashi
Journal:  Open Hypertens J       Date:  2010

Review 4.  Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.

Authors:  Aina He; Guo-Ping Shi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Usefulness of serum tryptase level as an independent biomarker for coronary plaque instability in a Chinese population.

Authors:  Meixiang Xiang; Jiusong Sun; Yan Lin; Jie Zhang; Han Chen; Dan Yang; Jianan Wang; Guo-Ping Shi
Journal:  Atherosclerosis       Date:  2011-01-26       Impact factor: 5.162

Review 6.  Mast cells as effectors in atherosclerosis.

Authors:  Ilze Bot; Guo-Ping Shi; Petri T Kovanen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-08-07       Impact factor: 8.311

Review 7.  Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.

Authors:  Louis J Dell'Italia; James F Collawn; Carlos M Ferrario
Journal:  Circ Res       Date:  2018-01-19       Impact factor: 17.367

8.  Chymase inhibition protects diabetic rats from renal lesions.

Authors:  Mei Zhang; Wen Huang; Jing Bai; Xiaodong Nie; Wen Wang
Journal:  Mol Med Rep       Date:  2016-05-10       Impact factor: 2.952

9.  The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.

Authors:  Fawzi Babiker; Aishah Al-Jarallah; Shaji Joseph
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

Review 10.  Mast cells in vulnerable atherosclerotic plaques--a view to a kill.

Authors:  Ken A Lindstedt; Mikko I Mäyränpää; Petri T Kovanen
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.